4//SEC Filing
Westby Keith 4
Accession 0001410939-23-000105
CIK 0001410939other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:45 PM ET
Size
9.0 KB
Accession
0001410939-23-000105
Insider Transaction Report
Form 4
IVERIC bio, Inc.ISEE
Westby Keith
SVP & COO
Transactions
- Exercise/Conversion
Common Stock
2023-07-03$2.94/sh+20,000$58,800→ 59,652 total - Sale
Common Stock
2023-07-03$39.45/sh−20,000$789,000→ 39,652 total - Exercise/Conversion
Stock Option (right to buy)
2023-07-03$2.94/sh−20,000$58,800→ 80,000 totalExercise: $2.94Exp: 2027-12-18→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2022.
- [F2]The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $39.37 to $39.56 per share on July 3, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- [F3]This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
Documents
Issuer
IVERIC bio, Inc.
CIK 0001410939
Entity typeother
Related Parties
1- filerCIK 0001696429
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:45 PM ET
- Size
- 9.0 KB